Introduction
Posterior Reversible Encephalopathy Syndrome (PRES) is a syndrome comprising headache, altered mentation, and seizures, associated with neuroimaging findings characteristic of subcortical edema in the posterior regions. It is usually seen in patients treated with immunosuppressants, in renal failure, or with eclampsia. Recurrent episodes of PRES in the same patient are rarely observed. Although seizures are often seen in PRES, EEG findings are not well described and include generalized and focal slowing with epileptiform discharges; there are limited reports of Periodic Lateralized Epileptiform Discharges (PLEDs) occurring during PRES, and there are no reports of PRES associated with PLEDs with subsequent development of epilepsy.
Case report
A twenty-eight-year old man with no prior medical history presented to an outside institution with headache, diarrhea, and renal failure and was subsequently diagnosed with Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS). He was initially treated with plasmapheresis and rituximab and was started on peritoneal dialysis. About four weeks after his presentation he experienced four generalized tonic-clonic (GTC) seizures in a twenty-four hour period. He was treated with levetiracetam for one week. Six months later he experienced two more GTC seizures. MRI was reported to show a ''PRES pattern'' and EEG was reported to show ''FIRDA pattern'' and he was restarted on levetiracetam. At that time he was transferred to our institution for further care.
Over the following eight months he experienced six episodes of PRES, precipitated by elevated blood pressure and not associated with metabolic abnormalities (such as uremia or electrolyte abnormalities) or use of immunosuppressants. During these episodes his blood pressures were elevated up to 200 over 100 mm of mercury, requiring transfer to the intensive care unit and treatment with IV anti-hypertensives. The significant elevations in his blood pressure were thought to be due to the patient's poor adherence to medications as well as the refractory nature of his hypertension due to chronic renal failure requiring hemodialysis. The onset of these episodes was consistently heralded by GTC seizures, prompting treatment with anti-epileptic medications, including valproic acid, phenytoin and levetiracetam. During some Seizure 20 (2011) [93] [94] [95] Posterior Reversible Encephalopathy Syndrome (PRES) is a syndrome comprising headache, altered mentation, and seizures, associated with neuroimaging findings characteristic of subcortical edema in the posterior regions. It is usually seen in patients treated with immunosuppressants, in renal failure, or with eclampsia. Recurrent episodes of PRES in the same patient are rarely observed. Although seizures are often seen in PRES, EEG findings are not well described and include generalized and focal slowing with epileptiform discharges; there are limited reports of Periodic Lateralized Epileptiform Discharges (PLEDs) occurring during PRES, and there are no reports of PRES associated with PLEDs with subsequent development of epilepsy. We report a patient we followed for one year with recurrent episodes of PRES associated with posteriorly dominant independent bilateral PLEDs who subsequently developed epilepsy. Patients with PRES and PLEDs should be treated aggressively with anti-hypertensive and antiepileptic agents in order to avoid potential complications. Although PRES is typically thought of as a reversible syndrome, this case illustrates that PRES may have serious long term sequelae after the reversible syndrome has resolved. This case highlights the importance of aggressive management of PRES as well as the prevention of subsequent episodes of PRES as patients may develop permanent brain dysfunction.
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of these episodes he experienced several days of reduplicative polyopsia involving both visual fields. MRI of the brain obtained during some of the episodes demonstrated T2 and FLAIR hyperintensities in the bilateral parieto-occipital regions with extension into the temporal lobes, with diffusion weighted imaging showing scattered areas of restricted diffusion in the posterior regions (Fig. 1A) . These changes resolved after each PRES episode, with the most recent brain MRI done when patient had normal mental status showing scattered subcortical T2 and FLAIR hyperintensities (Fig. 1B) . He also had several EEGs performed during the above-described PRES episodes which showed slowing of the posterior background rhythm and posteriorly-dominant bilateral independent PLEDs, more prominent over the left hemisphere (Fig. 1C) . At times PLEDs were occurring synchronously, suggestive of generalized periodic epileptiform discharges (GPEDs). Prolonged EEG monitoring as well as outpatient routine EEGs completed after the PRES episodes demonstrated resolution of PLEDs and normalization of the posterior background which coincided with improvement in his mental status. In the six months following the last PRES episode, he has been maintained on oral antihypertensive agents and levetiracetam 1000 mg twice daily with an additional 500 mg taken after hemodialysis. He has subsequently experienced several GTC seizures that were not associated with elevated blood pressures or prolonged postictal confusion.
Discussion
In 1996 Hinchey et al. 1 described a reversible posterior encephalopathy syndrome in thirteen patients with renal insufficiency, hypertension or immunosuppressed state. The transient clinical findings included headaches, vomiting, confusion, seizures and cortical blindness. Imaging of the brain showed extensive bilateral white-matter edema in the posterior regions of the cerebral hemispheres. Over the years imaging findings associated with the syndrome have been well described, but EEG findings remain less well described. EEG findings seen in PRES described in the literature include generalized and posterior focal slowing with epileptiform discharges. 2 There are also case reports of patients presenting with status epilepticus with seizures in the parietooccipital area. 3 We were only able to find two reports of PLEDs associated with PRES. 4, 5 PLEDs were described by Chatrian et al. in 1963 6 in patients with epilepsy, infarcts, alcoholism and systemic infections. They are always an abnormal electrographic finding, indicative of a focal or diffuse dysfunction of the cerebral cortex. Our patient had bilateral independent PLEDs that were posterior dominant, correlating with the posterior pathology occurring in PRES. The left-sided discharges showed larger amplitudes, despite the symmetrical appearance of imaging abnormalities.
It is important to be aware of the association of PRES with PLEDs and recurrent seizures. Patients presenting with PRES and mental status changes should be further evaluated with an EEG, and if PLEDs are seen treatment with an antiepileptic medication should be considered in the acute setting. While most patients with PRES recover fully and do not experience further seizures, there are rare instances of patients developing epilepsy 7 or experiencing a repeat episode of PRES. 3, 8, 9 Our patient is atypical as he had multiple episodes of PRES, had documented PLEDs and he developed epilepsy, requiring meticulous treatment with anti-hypertensive and anti-epileptic medications. He had several risk factors for the development of PRES, including end-stage renal disease requiring hemodialysis, non-adherence to medications and poorly controlled hypertension, as well as treatment with rituximab at the time of the initial episode of PRES. We propose that patients with PRES and PLEDs should have their blood pressure aggressively controlled and they should have prolonged EEG monitoring. Antiepileptic medications should be considered and offered to patients with PRES and PLEDs on a case by case basis. Treating the cause of PRES is important to prevent recurrent episodes. Each PRES episode should be treated with anti-hypertensive agents or removing the precipitating cause. Although PRES is typically thought of as a reversible syndrome, this case illustrates that recurrent episodes PRES, especially if associated with PLEDs, may have serious long term sequelae. This case highlights the importance of aggressive management and prevention of PRES as well as the prevention of seizures as patients may develop permanent brain dysfunction.
